Mahathir Bayena

QMines (ASX:QML) has intersected a 44m zone of copper mineralisation at its Mt Chalmers open pit in Queensland.

Perpetual Resources (ASX:PEC) completed a low-cost expansion of 62 new lode mining claims surrounding the historic Nevada Scheelite Tungsten Mine.

Arch Lending has announced plans to integrate tokenised equities as eligible borrowing collateral to expand onchain credit offerings, according to an exclusive report by Cointelegraph.

Department store retailer Myer (ASX:MYR) reported a full-year statutory loss of $276.5 million after taking a major non-cash impairment charge.

Patrys (ASX:PAB) has commenced human clinical testing by dosing the first participants in a Phase 1a trial for RLS-2202.

Insurance Australia Group (ASX:IAG) announced it will make a public benefits application to progress its proposed alliance with the Royal Automobile Club of Western Australia.

Cosmo Metals (ASX:CMO) has coordinated site preparations ahead of drill rig mobilisation to target high-grade copper, gold, and silver mineralisation at the Mona prospect.

Compass Therapeutics (NASDAQ:CMPX) shares declined after the U.S. Food and Drug Administration recommended an additional trial before the company submits a marketing application for tovecimig.

Vertex Pharmaceuticals (NASDAQ:VRTX) reported positive Phase 2b AMPLIFIED study results for inaxaplin in people with APOL1-mediated kidney disease and different levels of proteinuria.

Viking Therapeutics (NASDAQ:VKTX) announced positive topline results from a 33-week clinical study evaluating VK2735, its investigational GLP-1/GIP receptor agonist being developed for obesity treatment.